Company Ticker News September 28, 2021Novo Nordisk Settles Insulin Pricing Lawsuit For $100M 0 0 Share
Press Release August 9, 2021Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 5 August 2021 0 0 Share
Company Ticker News August 5, 2021BofA Upgrades Novo Nordisk, Says Wegovy Obesity Drug Launch 'Far Exceeded' Expectations 0 0 Share
Company Ticker News June 28, 2021Novo Nordisk's Higher Dose Of Semaglutide Trumped 1-mg Predecessor On Blood Sugar, Weight Reduction 0 0 Share
Press Release June 27, 2021Investigational 2.0 mg dose of Ozempic® (semaglutide) demonstrates superior reductions in blood sugar vs Ozempic® 1.0 mg in adults with type 2 diabetes in a phase 3 trial 0 0 Share
Company Ticker News June 23, 2021This Leading Healthcare Company's New Obesity Treatment Has Great Potential 0 0 Share
Press Release June 17, 2021Novo Nordisk Makes Big Move Into Diagnostics With $563 Million Investment 0 0 Share
